Skip to main content
. 2021 Sep 9;21:1009. doi: 10.1186/s12885-021-08741-4

Table 2.

Clinicopathological characteristic of lung cancer patients for survival analysis

All patients
(N = 52,472)
Variables N %
Sex
 Male 26,858 51.2
 Female 25,614 48.8
Race
 Non-Hispanic whites 43,818 83.5
 Non-Hispanic others 8654 16.5
Age (year)
  ≤ 68 23,070 44.0
  > 68 29,402 56.0
 Median (range) 70 (18–100)
Grade
 Well 5579 10.6
 Moderate 16,142 30.8
 Poor 16,855 32.1
 Undifferentiated 1745 3.3
 Unknown 12,151 23.2
Tumor Location
 Main bronchus 1271 2.4
 Upper lobe 30,463 58.0
 Middle lobe 2423 4.6
 Lower lobe 15,734 30.0
 Overlapping lesion of lung 607 1.2
 Unknown 1974 3.8
Radiotherapy
 No 37,612 71.7
 Yes 14,508 27.6
 Unknown 352 0.7
Chemotherapy
 No 39,127 74.6
 Yes 13,345 25.4
Marital status
 Married 27,089 51.6
 Non-married 23,504 44.8
 Unknown 1879 3.6
Surgical treatment
 None 22,136 42.2
 Limited resection 5784 11.0
 Lobectomy 23,228 44.2
 Pneumonectomy 984 1.9
 Unknown surgical approach 29 0.1
 Unknown 311 0.6
Histological subtypes
 Squamous cell carcinoma 16,691 31.8
 Adenocarcinoma 23,406 44.6
 Non-squamous and non-adenocarcinoma NSCLC 5128 9.8
 Small-cell carcinoma 2583 4.9
 Unknown non-sarcoma carcinoma 477 0.9
 Unknown NSCLC 4187 8.0
T classification
 T1a 1752 3.3
 T1b 9439 18.0
 T1c 8412 16.1
 T2a 11,509 21.9
 T2b 3784 7.2
 T3 4180 8.0
 T4 11,043 21.0
 Tx (occult) 2353 4.5

NSCLC non-small cell lung cancer